In addition, LAIR1 showed an independent role in predicting the time to first treatment (TTFT), although LAIR1’s ability to predict the survival of CLL patients is still to be determined [188]. The gene discussed is LAIR1; the disease is B-cell chronic lymphocytic leukemia.